The first relates to the sales of finished probiotic supplements with Lactobacillus reuteri, the other for the use of Lactobacillus reuteri as ingredient in food. Launches are planned for 2017.
The first agreement concerns the exclusive rights to sell probiotic supplements with BioGaia’s patented strains of Lactobacillus reuteri at drugstores, supermarkets and similar outlets.
Depending on the product category, products will be sold under Kabaya, Ohayo and/or BioGaia brand.
The other agreement is an exclusive license, giving Ohayo Dairy Products the rights to use strains of Lactobacillus reuteri in food, such as drinks and dairy products.
“The agreements are long term and include exclusivity fees and minimum royalties over the term of the contracts, which will have a substantial effect on BioGaia’s Japanese business,” said the company.
“Due to confidentiality, the amounts of the fees and the royalties cannot be disclosed.”
Nippon Kabaya Ohayo Holdings Inc. is a privately-owned company with headquarters in Tokyo. It has a group of 13 companies with more than 3,000 employees.
Kabaya Foods and Ohayo Dairy are Japan´s seventh largest confectionery and dairy companies respectively.
“Through these two milestone agreements with Nippon Kabaya Ohayo Holdings Inc. we have secured another trusted partner in the complex Japanese market. In addition to the marketing and sales of our supplements we look forward to the creation of innovative functional foods based on our Lactobacillus reuteri strains,” said BioGaia managing director Axel Sjöblad.